Z-3044-2020 Class II Terminated
FDA device recall Z-3044-2020 was initiated by Ameditech Inc on Aug 18, 2020 and is designated Class II. Reason for recall: Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling. The recall status is terminated (terminated Sep 30, 2024). Affected quantity: 26,775 units.
Recall details
- Product Type
- Devices
- Report Date
- Oct 7, 2020
- Initiation Date
- Aug 18, 2020
- Termination Date
- Sep 30, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 26,775 units
Product description
TDDA Drugs of Abuse Cup(AMT Item/ AMT Description): TDDA-6MBAU-CUP /"TDDA Drugs of Abuse Cup AMP300/BZO200/COC300/MET300/OPI300/ THC50 with Cr, Ni, pH, Bl, S.G."
Reason for recall
Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling.
Distribution pattern
US - Nationwide OUS - Australia, France, Germany, New Zealand, Singapore and Spain
Code information
ALL Lots Within Expiry
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-3044-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026